POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY

POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY

Bibliographic Details
Main Authors: H.Y. Yang MD, C.L. Yen
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921005283
id doaj-2cf45471d94d43648e2ac42d3eb06cb8
record_format Article
spelling doaj-2cf45471d94d43648e2ac42d3eb06cb82021-04-18T06:30:09ZengElsevierKidney International Reports2468-02492021-04-0164S158S159POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDYH.Y. Yang MD0C.L. Yen1Chang Gung Memorial Hospital, Nephrology, Taoyuan City, TaiwanChang Gung Memorial Hospital, Nephrology, Taipei, Taiwanhttp://www.sciencedirect.com/science/article/pii/S2468024921005283
collection DOAJ
language English
format Article
sources DOAJ
author H.Y. Yang MD
C.L. Yen
spellingShingle H.Y. Yang MD
C.L. Yen
POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
Kidney International Reports
author_facet H.Y. Yang MD
C.L. Yen
author_sort H.Y. Yang MD
title POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
title_short POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
title_full POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
title_fullStr POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
title_full_unstemmed POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY
title_sort pos-365 pioglitazone reduces mortality and adverse events in type 2 diabetes mellitus patients with advanced chronic kidney disease: national cohort study
publisher Elsevier
series Kidney International Reports
issn 2468-0249
publishDate 2021-04-01
url http://www.sciencedirect.com/science/article/pii/S2468024921005283
work_keys_str_mv AT hyyangmd pos365pioglitazonereducesmortalityandadverseeventsintype2diabetesmellituspatientswithadvancedchronickidneydiseasenationalcohortstudy
AT clyen pos365pioglitazonereducesmortalityandadverseeventsintype2diabetesmellituspatientswithadvancedchronickidneydiseasenationalcohortstudy
_version_ 1721523265941274624

Similar Items